Herein, we sought to evaluate whether orlistat could improve metabolic syndrome and oxidative stress in HFD-induced MAFLD rats and activate Nrf2/Keap1 signaling pathway to exert its protective and therapeutic effects. Here, KEAP1 is linked to metabolic syndrome.